Queensland Research Centre for Peripheral Vascular Disease, School of Medicine and Dentistry, James Cook University, Townsville 4811, Australia.
Atherosclerosis. 2013 Aug;229(2):549-55. doi: 10.1016/j.atherosclerosis.2013.04.030. Epub 2013 May 16.
Current guidelines contain no advice on how to manage obesity and underweight in patients with peripheral vascular disease (PVD).
The aim of this study was to assess the association of underweight, overweight and obesity with mortality in patients with PVD.
We recruited 1472 patients with a broad range of presentations of PVD. Underweight, overweight and obesity were defined by body mass index (BMI) and associated with mortality using Kaplan Meier and Cox proportional hazard analyses.
Survival at 3 years was 37.5, 78.1, 86.8 and 87.0% for patients that were underweight, normal weight, overweight and obese at recruitment, respectively, p<0.001. Patients that were underweight had approximately twice the risk of dying (RR 2.15, 95% CI 1.31-3.55, p=0.003), while patients that were overweight (RR 0.67, 95% CI 0.49-0.91, p=0.011) or obese (RR 0.59, 95% CI 0.41-0.85, p=0.005) had approximately half the risk of dying, after adjustment for other risk factors and using normal weight subjects as the reference group. 823 patients had waist circumference measured at recruitment. Patients with waist circumference in the top quartile had half the risk of dying (RR 0.50, 95% CI 0.26-0.98, p=0.045). In 267 patients we assessed the relationship between BMI and abdominal fat volumes using computed tomography. BMI was highly correlated with both intra-abdominal and subcutaneous fat volumes.
Obesity whether assessed by BMI or central fat deposition is associated with reduced risk of dying in patients with established PVD. Underweight is highly predictive of early mortality in patients with PVD.
目前的指南中没有关于如何管理外周血管疾病(PVD)患者的肥胖和体重不足的建议。
本研究旨在评估 PVD 患者体重不足、超重和肥胖与死亡率的关系。
我们招募了 1472 名患有各种 PVD 表现的患者。体重不足、超重和肥胖通过体重指数(BMI)来定义,并通过 Kaplan-Meier 和 Cox 比例风险分析与死亡率相关联。
在 3 年内,体重不足、正常体重、超重和肥胖的患者的生存率分别为 37.5%、78.1%、86.8%和 87.0%,p<0.001。体重不足的患者死亡风险约为两倍(RR 2.15,95%CI 1.31-3.55,p=0.003),而超重(RR 0.67,95%CI 0.49-0.91,p=0.011)或肥胖(RR 0.59,95%CI 0.41-0.85,p=0.005)的患者,在调整其他危险因素并以正常体重患者为参考组后,死亡风险约为一半。在 1472 名患者中有 823 名患者在招募时测量了腰围。腰围处于最高四分位数的患者死亡风险降低一半(RR 0.50,95%CI 0.26-0.98,p=0.045)。在 267 名患者中,我们评估了 BMI 和腹部脂肪量之间的关系。BMI 与腹内和皮下脂肪量高度相关。
无论是否通过 BMI 还是中央脂肪沉积来评估肥胖,都与已确诊的 PVD 患者的死亡风险降低有关。体重不足高度预测 PVD 患者的早期死亡率。